Pletal (Cilostazol) — Patient Information (Australia)

Pletal contains the active ingredient cilostazol. It is used to help improve walking distance in certain people with peripheral arterial disease (PAD), a condition where blood flow to the legs is reduced due to narrowed arteries.

This information is designed to be patient-friendly and practical. It explains how cilostazol works, how it is taken, what to expect, and important safety considerations—particularly interactions with other medicines and alcohol.

Quick product overview

What is Pletal used for?

The main indication for cilostazol is treatment of symptoms of intermittent claudication due to PAD. Intermittent claudication is pain, cramping, or discomfort in the legs during walking that improves with rest.

Typical benefits

• Increases walking distance before leg pain starts.
• May improve overall walking performance when combined with lifestyle measures and walking training.

Cilostazol is not a substitute for comprehensive PAD management (e.g., risk-factor control, supervised exercise therapy, and, when appropriate, medicines such as statins and antiplatelet therapy).

How Pletal works (mechanism of action)

Cilostazol works through multiple actions that can improve blood flow and reduce “stickiness” of platelets:

• Anti-platelet effect: Cilostazol inhibits platelet aggregation (reduces clumping). This helps reduce microvascular problems that can worsen symptoms during walking.
• Vasodilation: It can relax arterial smooth muscle, which may improve blood flow to working muscles.
• Increased cyclic AMP (cAMP) signalling: A key part of its effect is raising cAMP in platelets and vascular cells, supporting both anti-platelet and vasodilatory effects.

Together, these actions aim to improve symptoms of PAD and help you walk further before pain limits activity.

Pharmacokinetics (how the body processes it)

Pharmacokinetics explains what happens to the medicine after you swallow it—absorption, metabolism, and how quickly it leaves the body.

• Absorption: Cilostazol is absorbed after oral dosing. Concentrations rise after taking a dose and then gradually fall.
• Metabolism: Cilostazol is metabolised mainly by CYP enzymes, particularly CYP3A4 and CYP2C19 (important for drug–drug interactions).
• Active metabolites: The body forms metabolites that may also contribute to overall activity.
• Half-life: The effective duration is influenced by both the parent drug and metabolites. Clinically, this supports twice-daily dosing for typical regimens.
• Elimination: Metabolites are excreted mainly via renal (kidney) and other pathways.

Your individual response may vary based on age, liver function, kidney function, and other medicines you take.

When and how to take Pletal (timing and dosing)

Typical dosing (adult)

A commonly used adult regimen for cilostazol is:

• 100 mg twice daily (morning and evening), unless your clinician has adjusted it.

Because medicine availability and local guidance can differ, always follow the directions on your product packaging and the instructions provided with your specific supply.

How to space doses

• Try to take doses about 12 hours apart (e.g., morning and evening).
• If you miss a dose, take it when you remember unless it is close to your next dose—then skip the missed dose and resume your schedule.
• Do not double up to make up for a missed dose.

Is it okay to take with food?

You can generally take cilostazol with or without food. Some people find taking it after meals reduces stomach discomfort.

Consistency helps—if you normally take it with food, continue doing so unless advised otherwise.

Food interactions

Cilostazol’s key interaction concerns are typically with other medicines (especially those affecting CYP enzymes), rather than with foods. However, some practical points are helpful:

• Grapefruit and grapefruit juice: may affect CYP3A4 activity in some individuals, potentially increasing cilostazol exposure. Consider limiting or avoiding grapefruit products unless your pharmacist says it is safe for you.
• High alcohol intake with meals: can worsen side effects like dizziness or headache and may increase bleeding risk when combined with anti-platelet effects.

If you have dietary restrictions or are using supplements (e.g., herbal products), check with a pharmacist for compatibility.

Alcohol and medicine interactions

Because cilostazol has anti-platelet/vasodilatory effects, alcohol may add to common side effects and potentially increase bleeding risk when taken in higher amounts.

What to consider with alcohol

• Moderation is important. Heavy drinking may increase dizziness, headache, and gastrointestinal irritation.
• Bleeding risk: If you also take other medicines that affect bleeding (e.g., aspirin, clopidogrel, warfarin/other anticoagulants), alcohol and drug combinations can increase risk of bruising or bleeding.
• Driving and machinery: If you feel light-headed, avoid driving or operating machinery.

Tell your healthcare team if you:

• Drink alcohol regularly or in large amounts
• Have a history of stomach ulcers or bleeding
• Take additional blood-thinning medicines

Medicine interactions (important)

Cilostazol interacts with medicines that influence CYP3A4 and CYP2C19, and with medicines that affect bleeding. Always review your full medication list (including over-the-counter products) with a pharmacist.

Common interaction categories

• CYP3A4 inhibitors (may increase cilostazol levels): Examples include some antifungals and certain antibiotics. Increased levels can raise risk of side effects such as headache, palpitations, or bleeding.
• CYP2C19 inhibitors (may also increase exposure): Some medicines can reduce metabolism, increasing cilostazol concentration.
• Other antiplatelet medicines / anticoagulants (may increase bleeding tendency): Examples include aspirin, clopidogrel, and warfarin/other anticoagulants.
• Drugs that may affect heart rhythm or have cardiovascular effects: Cilostazol can cause palpitations in some people, so caution is needed with certain cardiac medicines.

What to do

• Carry an up-to-date list of your medicines and allergies.
• Ask a pharmacist before starting new medicines, including “cold and flu” products.
• If you’re prescribed a medicine that is known to interact, dose adjustment or monitoring may be required.

This product page provides general information only and cannot cover every possible interaction. For personal safety, check before use.

Who should be cautious? (safety profile and contraindications)

Cilostazol is not suitable for everyone. Some people need to avoid it, while others may need careful monitoring or dose changes.

Important safety considerations

• Heart failure: Do not use cilostazol if you have congestive heart failure (it may worsen outcomes).
• Bleeding risk: Because cilostazol affects platelets, avoid it or use with caution if you have active bleeding, a history of bleeding in the gut, or conditions that predispose to bruising.
• Liver or kidney impairment: Cilostazol is metabolised and cleared by the body; impairment may increase drug exposure. Your clinician may adjust treatment or avoid it depending on severity.
• Low blood pressure or dizziness: Side effects such as dizziness may occur; take care when getting up quickly.

Common side effects

• Headache
• Dizziness or light-headedness
• Palpitations (awareness of heartbeat)
• Diarrhoea or gastrointestinal discomfort
• Nausea
• Swelling or mild fluid retention (less common)

Seek urgent medical help if you experience

• Signs of severe bleeding (e.g., black/tarry stools, vomiting blood, blood in urine, unusual or large bruises)
• Chest pain, fainting, or severe shortness of breath
• Severe or persistent rapid heartbeat or feeling very unwell
• Allergic reactions (e.g., swelling of face/lips, rash with breathing difficulty)

Practical use tips (getting the most from treatment)

Medication can help, but lifestyle and monitoring often make a major difference in PAD outcomes.

• Use an exercise routine: If you have intermittent claudication, supervised or structured walking programs can improve walking distance. Try to walk regularly within tolerable limits.
• Stop smoking if you smoke: Smoking strongly worsens PAD.
• Control cardiovascular risk factors: Keep blood pressure, diabetes, and cholesterol under review with your healthcare team.
• Watch for side effects early: Headache or palpitations may settle in some people, but persistent symptoms should be discussed.
• Know what to do if you miss a dose: Use your “next dose” rule rather than doubling.
• Keep an updated medication list: Interactions are a common preventable cause of problems.

What results can you expect?

Many people notice improvements gradually as walking tolerance improves. Response can vary. If you don’t feel any benefit after an adequate trial (as advised by your clinician), reassessment may be needed.

Keep track of your walking distance or time to onset of pain (for example, in a simple diary) to discuss progress at review appointments.

Alternatives to Pletal (cilostazol)

Treatment options for PAD/intermittent claudication depend on your symptoms and overall health. Alternatives may include:

• Structured exercise therapy (often a core part of treatment; may be supervised)
• Other medicines used for cardiovascular risk reduction: statins and appropriate antiplatelet therapy to reduce cardiovascular events
• Other approaches when symptoms are severe: referral for vascular assessment and possible procedures (e.g., revascularisation) may be considered in suitable cases

While cilostazol is commonly used specifically for claudication symptoms in appropriate patients, the “best” option depends on your medical history and risk profile. A pharmacist or clinician can help explain the most suitable plan for you.

Market and legal context for Australia (general)

In Australia, medicines are regulated under the national framework administered by the TGA (Therapeutic Goods Administration). Medicines may be supplied depending on their approved indications and scheduling status.

For online pharmacy supply, availability may vary by brand, pack size, and TGA listing or distribution arrangements. Always confirm the product details on your chosen pharmacy site and ensure the medicine matches the intended active ingredient and strength.

Recent guidance (what matters for patients)

Australian and international PAD guidance generally emphasises a combined approach: lifestyle measures, cardiovascular risk management, and symptom-directed therapy where suitable. In recent years, clinicians have increasingly focused on:

• Using evidence-based cardiovascular risk reduction (e.g., statins where appropriate)
• Prioritising supervised or structured exercise programs
• Careful medication selection to minimise harm from drug interactions and bleeding risk
• Regular review of symptoms and safety (e.g., monitoring for side effects)

Local prescribing practices may also reflect updates to safety information and product-specific factors.

Delivery and availability (what to expect)

Online pharmacy supply in Australia typically includes:

• Product availability checks: Stock may vary; some strengths or pack sizes can be temporarily unavailable.
• Dispatch timelines: Many pharmacies dispatch within 1–2 business days once an order is confirmed.
• Delivery estimates: Courier or Australia Post delivery times vary by state and service level.
• Packaging: Medicines are usually packed in accordance with cold-chain or ambient requirements as applicable.

To receive your order promptly, ensure your delivery address is correct and that someone can accept the parcel if required.

FAQ about Pletal (cilostazol)

1) Is Pletal the same as cilostazol?

Yes. Pletal is a brand name that contains cilostazol as the active ingredient.

2) How long does it take to work?

Some people may notice changes gradually. Improvement is usually assessed over a course of treatment with symptom monitoring (e.g., walking time/distance before pain). If there is no meaningful improvement after a suitable trial, discuss review options with your healthcare team.

3) Can I take Pletal with my other heart medicines?

It depends. Many cardiovascular medicines can be used together safely, but some combinations increase risks (especially bleeding risk or heart-related side effects). Always check your full list of medicines with a pharmacist.

4) What should I do if I miss a dose?

Take it when you remember unless it is close to your next scheduled dose. If it’s close, skip the missed dose and continue as usual. Do not double doses.

5) Does Pletal increase bleeding?

Cilostazol affects platelet function, which may increase bleeding tendency in some people. You should seek urgent help if you notice signs of significant bleeding (black stools, blood in urine, unusual bruising, or vomiting blood).

6) Can I drink alcohol while taking Pletal?

Moderate alcohol may be tolerated by some people, but heavy alcohol intake can increase dizziness and may raise bleeding risk—especially if you take other medicines that affect bleeding. If you drink regularly, ask a pharmacist for personalised advice.

7) Are there foods I should avoid?

Food interactions are generally less prominent than medicine interactions. However, consider limiting grapefruit products because they may affect drug metabolism in some individuals. If you have concerns, ask a pharmacist.

8) Who should not use cilostazol?

Cilostazol is generally not suitable for people with congestive heart failure and may not be suitable for those with certain bleeding risks or significant liver/kidney impairment. Check your situation with a pharmacist or clinician.

9) What side effects are most common?

Headache, dizziness, palpitations, diarrhoea, nausea, and gastrointestinal discomfort are among the more commonly reported side effects.

10) What are common signs that I should stop and get help?

Seek urgent care for severe bleeding, fainting, chest pain, severe shortness of breath, or signs of allergic reaction. Persistent troublesome symptoms should also be discussed promptly with a healthcare professional.

Important final notes

Medicines should be used according to the instructions provided with your product and the advice of your healthcare professional. If you are unsure about whether cilostazol is suitable for you or whether your other medicines are safe to combine, speak to a pharmacist before starting.